Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.

Autor: Kähler, Christian M, Graziadei, Ivo, Vogelsinger, Helene, Desole, Susanna, Cima, Katharina, Vogel, Wolfgang
Zdroj: Wiener Klinische Wochenschrift; Apr2011, Vol. 123 Issue 7/8, p248-252, 5p, 1 Chart, 2 Graphs
Databáze: Complementary Index